Focus on the development and production of Active Pharmaceutical Ingredients (APIs)
Seven Star Pharmaceutical Co., Ltd. was founded in 1962 and is located in Tu Cheng District, New Taipei City, Taiwan, covering an area of 13,000 m2. Adhering to the quality policy of " Customer Satisfaction, Wisdom Combination, Quality Improvement, and Striving for Excellence" for more than 50 years, we has obtained cGMP certificates from the US FDA and TFDA. We focus on the development and production of Active Pharmaceutical Ingredients (APIs). The products are sold to dozens of countries such as the United States, Japan, Europe, Canada, Mexico ... etc.
Expand the production capacity and increase product variety
In March 2016, Synmosa Group and InnoPharmax merged and acquired Seven Star. Seven Star is the one and only API factory under Synmosa Group. Currently, the API products of Seven Star are mainly exported, our main products are: Guaifenesin, Methocarbamol, Gadopentetate dimeglumine, Sapropterin Dihydrochloride, Gadoterate Meglumine, Acetylcysteine and Carbocisteine. In order to expand the production capacity and increase product variety, Seven Star carried out plant reconstruction and equipment upgrade in 2019. Under the cGMP standard requirements, Seven Star insist to update equipment and implement quality policies. Now that international regulations are becoming stricter with regard to API regulations, Seven Star also demands ourselves with high standard, establish and maintain a complete quality system and R & D team in order to continuously provide customers with the latest and highest quality products.